CHM chimeric therapeutics limited

Say 2 years for phase 1b.Best case 3 years for phase 2...

  1. 1,717 Posts.
    lightbulb Created with Sketch. 540
    Say 2 years for phase 1b.

    Best case 3 years for phase 2 (registrational). Plus another year to go through approval process.

    FDA approval 2029-2030.

    Hopefully knock a couple of years off with fast-track designation and continued good results. 2028 surely best-case scenario for approval?

    .
    https://hotcopper.com.au/data/attachments/5763/5763664-090175560f969f91c024c9dbaa8b0d0b.jpg
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.4¢
Change
0.000(0.00%)
Mkt cap ! $8.060M
Open High Low Value Volume
0.4¢ 0.4¢ 0.4¢ $28.14K 7.037M

Buyers (Bids)

No. Vol. Price($)
1 243067 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 14771167 22
View Market Depth
Last trade - 15.39pm 20/06/2025 (20 minute delay) ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.